Sequoia China, HighLight Capital Back $16M Series A Round In US Biotech Start-Up
April 11, 2019 — 12:39 CST
This Data Is Locked!
This area is available only to Subscribers.
Sequoia Capital China and Chinese healthcare-focused investment firm HighLight Capital have backed a US$16 million series A round of financing in America-based biotechnology company Cullgen... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals